Myriad Genetics (MYGN) Cash & Equivalents Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Cash & Equivalents Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 20.63% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -21.29% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 186.05% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 22.30% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 12.96% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 21.60% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 11.90% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -2.16% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -5.74% |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | 35.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.51% |
| Dec 31, 2025 | 46.09% |
| Sep 30, 2025 | 45.55% |
| Jun 30, 2025 | -19.48% |
| Mar 31, 2025 | -5.26% |
| Dec 31, 2024 | -22.48% |
| Sep 30, 2024 | 31.45% |
| Jun 30, 2024 | -10.12% |
| Mar 31, 2024 | 80.78% |
| Dec 31, 2023 | 132.16% |
| Sep 30, 2023 | -30.08% |
| Jun 30, 2023 | -1.34% |
| Mar 31, 2023 | -67.36% |
| Dec 31, 2022 | -77.89% |
| Sep 30, 2022 | -63.18% |
| Jun 30, 2022 | -11.99% |
| Mar 31, 2022 | 10.28% |
| Dec 31, 2021 | 120.00% |
| Sep 30, 2021 | 149.54% |
| Jun 30, 2021 | -27.67% |